Why is Amerise BioScie falling/rising?

As of 17-Sep, Amerise Biosciences Ltd is experiencing a price increase, currently at 0.74, which reflects a rise of 0.04 or 5.71%. The stock has outperformed its sector by 5.77% today, indicating a positive movement relative to its peers. However, despite this short-term gain, the stock has shown a significant decline year-to-date of 38.84%, and over the past three years, it has decreased by 27.45%. The stock is currently trading above its 5-day and 20-day moving averages, but it remains below its longer-term moving averages (50-day, 100-day, and 200-day). Additionally, there has been a notable drop in investor participation, with delivery volume falling by 61.28% against the 5-day average, which could indicate a lack of sustained interest in the stock.
In the broader market context, Amerise Biosciences' short-term return of 5.71% over the past week significantly outpaces the Sensex's return of 1.56% during the same period. However, the stock's year-to-date performance is considerably worse than the Sensex, which has gained 5.83% this year. This contrast highlights the challenges faced by Amerise Biosciences in maintaining investor confidence despite recent positive movements. Overall, while the stock is currently rising, its long-term performance and declining investor participation suggest underlying issues that may affect its future trajectory.